Literature DB >> 29752575

Expression pattern of cdkl5 during zebrafish early development: implications for use as model for atypical Rett syndrome.

Marta Vitorino1, Nídia Cunha2, Natércia Conceição3,2,4, M Leonor Cancela3,2,4.   

Abstract

Atypical Rett syndrome is a child neurodevelopmental disorder induced by mutations in CDKL5 gene and characterized by a progressive regression in development with loss of purposeful use of the hands, slowed brain and head growth, problems with walking, seizures, and intellectual disability. At the moment, there is no cure for this pathology and little information is available concerning animal models capable of mimicking its phenotypes, thus the development of additional animal models should be of interest to gain more knowledge about the disease. Zebrafish has been used successfully as model organism for many human genetic diseases; however, no information is available concerning the spatial and temporal expression of cdkl5 orthologous in this organism. In the present study, we identified the developmental expression patterns of cdkl5 in zebrafish by quantitative PCR and whole-mount in situ hybridization. cdkl5 is expressed maternally at low levels during the first 24 h of development. After that the expression of the gene increases significantly and it starts to be expressed mainly in the nervous system and in several brain structures, such as telencephalon, mesencephalon and diencephalon. The expression patterns of cdkl5 in zebrafish is in accordance with the tissues known to be affected in humans and associated to symptoms and deficits observed in Rett syndrome patients thus providing the first evidence that zebrafish could be an alternative model to study the molecular pathways of this disease as well as to test possible therapeutic approaches capable of rescuing the phenotype.

Entities:  

Keywords:  Brain; Cdkl5; Rett syndrome; Zebrafish

Mesh:

Substances:

Year:  2018        PMID: 29752575     DOI: 10.1007/s11033-018-4180-1

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  26 in total

1.  High-resolution in situ hybridization to whole-mount zebrafish embryos.

Authors:  Christine Thisse; Bernard Thisse
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 2.  Zebrafish: a model system for the study of human disease.

Authors:  K Dooley; L I Zon
Journal:  Curr Opin Genet Dev       Date:  2000-06       Impact factor: 5.578

Review 3.  Embryonic alcohol exposure: Towards the development of a zebrafish model of fetal alcohol spectrum disorders.

Authors:  Robert Gerlai
Journal:  Dev Psychobiol       Date:  2015-06-16       Impact factor: 3.038

4.  Prevention of unpredictable chronic stress-related phenomena in zebrafish exposed to bromazepam, fluoxetine and nortriptyline.

Authors:  Matheus Marcon; Ana P Herrmann; Ricieri Mocelin; Cassiano L Rambo; Gessi Koakoski; Murilo S Abreu; Greicy M M Conterato; Luiza W Kist; Maurício R Bogo; Leila Zanatta; Leonardo J G Barcellos; Angelo L Piato
Journal:  Psychopharmacology (Berl)       Date:  2016-08-25       Impact factor: 4.530

5.  Stages of embryonic development of the zebrafish.

Authors:  C B Kimmel; W W Ballard; S R Kimmel; B Ullmann; T F Schilling
Journal:  Dev Dyn       Date:  1995-07       Impact factor: 3.780

Review 6.  Evolution of protein kinase signaling from yeast to man.

Authors:  Gerard Manning; Gregory D Plowman; Tony Hunter; Sucha Sudarsanam
Journal:  Trends Biochem Sci       Date:  2002-10       Impact factor: 13.807

Review 7.  Animal models of human disease: zebrafish swim into view.

Authors:  Graham J Lieschke; Peter D Currie
Journal:  Nat Rev Genet       Date:  2007-05       Impact factor: 53.242

8.  Commentary: Zebrafish as a Model for Epilepsy-Induced Cognitive Dysfunction: A Pharmacological, Biochemical and Behavioral Approach.

Authors:  Avishek Amar
Journal:  Front Pharmacol       Date:  2017-11-21       Impact factor: 5.810

9.  Characterisation of CDKL5 Transcript Isoforms in Human and Mouse.

Authors:  Ralph D Hector; Owen Dando; Nicoletta Landsberger; Charlotte Kilstrup-Nielsen; Peter C Kind; Mark E S Bailey; Stuart R Cobb
Journal:  PLoS One       Date:  2016-06-17       Impact factor: 3.240

10.  Developmental suppression of schizophrenia-associated miR-137 alters sensorimotor function in zebrafish.

Authors:  J Giacomotto; A P Carroll; S Rinkwitz; B Mowry; M J Cairns; T S Becker
Journal:  Transl Psychiatry       Date:  2016-05-24       Impact factor: 6.222

View more
  4 in total

1.  Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder.

Authors:  Tatiana Varela; Débora Varela; Gil Martins; Natércia Conceição; M Leonor Cancela
Journal:  Sci Rep       Date:  2022-06-04       Impact factor: 4.996

Review 2.  Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder.

Authors:  Syouichi Katayama; Noriyuki Sueyoshi; Tetsuya Inazu; Isamu Kameshita
Journal:  Neural Plast       Date:  2020-06-05       Impact factor: 3.599

3.  Novel preclinical model for CDKL5 deficiency disorder.

Authors:  Rita J Serrano; Clara Lee; Alon M Douek; Jan Kaslin; Robert J Bryson-Richardson; Tamar E Sztal
Journal:  Dis Model Mech       Date:  2022-03-08       Impact factor: 5.758

Review 4.  Sleep Disorders in Rett Syndrome and Rett-Related Disorders: A Narrative Review.

Authors:  Giorgia Tascini; Giovanni Battista Dell'Isola; Elisabetta Mencaroni; Giuseppe Di Cara; Pasquale Striano; Alberto Verrotti
Journal:  Front Neurol       Date:  2022-03-01       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.